Education
About Us
Working with TipRanks
Follow Us
Jess Roper Insider Profile
4 Followers
Jess Roper, SVP, CFO at Dexcom, holds 15.75K shares in Revelation Biosciences (Ticker: REVB), holds 0.00 shares in BIOLASE (Ticker: BIOLQ), holds 75.99K shares in Dexcom (Ticker: DXCM).
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-24.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jess Roper holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jess Roper
Jess Roper's Trading History
Dexcom
Mar 24, 2017
SVP, CFO
Uninformative Sell
151.92K
$4.53M
BIOLASE
May 02, 2022
Director
Uninformative Sell
―
$0.00
Revelation Biosciences
Oct 31, 2025
Director
Uninformative Buy
20.00K
$15.46K
List of latest transactions for each holding click on a transaction to see Jess Roper's performance on stock
You May Also Like
Jess Roper insider profile FAQ
What is the percentage of profitable transactions made by Jess Roper?
The percentage of profitable transactions made by Jess Roper is 33%.
What is the average return per transaction made by Jess Roper?
The average return per transaction made by Jess Roper is -24.80%.
What stocks does Jess Roper hold?
Jess Roper holds: DXCM, BIOLQ, REVB stocks.
What was Jess Roper’s latest transaction?
Jess Roper latest transaction was an Uninformative Buy of $20.00K.
What was Jess Roper's most profitable transaction?
Jess Roper’s most profitable transaction was an Informative Sell of DXCM stock on November 16, 2015. The return on the trade was 14.10%.
What is Jess Roper's role in Dexcom?
Jess Roper's role in Dexcom is SVP, CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.